The Importance of Ophthalmological Examination in Erythematous Lupus: A Case Report and Literature Review

Lucrèce Joanelle Vydalie Eriga *

Mohamed V Military Hospital in Rabat, Morocco.

Youssouou Souley Abdoul Salam

Niamey Army Hospital, Niger.

Fadhloullahi Khidrou Sambou Oumarou

Mohamed V Military Hospital in Rabat, Morocco.

Keith Adjatin Rolyf Awore

Mohamed V Military Hospital in Rabat, Morocco.

Arnaud Hugues Yempabou Yonli

Mohamed V Military Hospital in Rabat, Morocco.

Sadiki Samah

Mohamed V Military Hospital in Rabat, Morocco.

Yassine Mouzari

Mohamed V Military Hospital in Rabat, Morocco.

Abdelbarre Oubaaz

Mohamed V Military Hospital in Rabat, Morocco.

*Author to whom correspondence should be addressed.


Abstract

Objective: Underline the importance of ophthalmological clinical examination in the management of Lupus.

Case Report: A 25-year-old female with no previous medical history presented 15 days ago with erythematous, non-itchy, scaly maculo-papular lesions of the face in the form of a butterfly's wing, evolving in a febrile context with altered general condition, constipation and memory problems. The diagnosis of systemic lupus erythematosus was made on the basis of the clinical symptoms, biological results and the biopsy. Treatment was based on a synthetic antimalarial agent. An ophthalmological opinion was sought with a view to the introduction of synthetic antimalarials.

Clinical examination revealed corrected visual acuity of 10/10 in the right eye and 10/10 in the left. Biomicroscopy of both eyes showed infiltration of the lower eyelids, and examination of the retina revealed diffuse cotton wool spots around the vessels, a sharply excavated papilla rated 0.4 on the right and 0.3 on the left, good-caliber vessels without vascular sheathing, and good macular reflexion. Fluorescein angiography of both eyes showed no signs of retinal ischaemia (at the posterior pole and retinal periphery) or diffusion at any time during the examination.  The patient was treated with hydroxychloroquine, dermocorticoids and local care for the skin lesions. The first month was marked by an improvement in skin signs, with stabilisation of the cotton wool spots on the fundus. However, dry keratoconjunctivitis appeared, leading to the prescription of a wetting agent and a vitamin A-based healing agent.

Keywords: Systemic lupus erythematosus, cotton wool spots, retinal damage


How to Cite

Eriga, L. J. V., Salam, Y. S. A., Oumarou, F. K. S., Awore, K. A. R., Yonli, A. H. Y., Samah, S., Mouzari, Y., & Oubaaz, A. (2024). The Importance of Ophthalmological Examination in Erythematous Lupus: A Case Report and Literature Review. Asian Journal of Research and Reports in Ophthalmology, 7(1), 74–79. Retrieved from https://journalajrrop.com/index.php/AJRROP/article/view/100

Downloads

Download data is not yet available.

References

Stafford-Brady FJ, Urowitz MB, Gladman DD, et al. Lupus retinopathy: patterns, associations and prognosis. Arthritis Rheum 1988;31:1105–1110.

Gold DH, Morris A, Henkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 1972;56:800–804.

Nag TC, Wadhwa S. Vascular changes of the retina and choroids in SLE: pathology and pathogenesis. Curr Neurovasc Res. 2006;3:159-168

Gelman R, Whitman MC, Horowitz J. Retinal Vasculature Remodeling In A Case Of Systemic Lupus Erythematosus Vaso-Occlusive RetinopathY. Retinal Cases and Brief Reports. Winter. 2014;8(1):77.

Petri M, Orbai AM, Alarco´ n GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012; 64:2677–2686.

Silpa-archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. JANV.2016;100(1):135‑41.

Zaki M, Lazrak Z, Lahlou G, Fadil A, F. Benjellon BA. Manifestations ophtalmologiques du lupus chez l’enfant. Journal Marocain des Sciences Médicales. 2014;19(3):37‑41.

Laroche L, Saraux H, Brissaud P. Vascularite rétinienne au cours du lupus érythémateux disséminé. J Fr Ophtalmol. 1984;7:193-00

Damak C, Moez J, Chebbi D, Garbaa S, Frikha F, Turki C, et al. Lupus érythémateux systémique révélé par une vascularite rétinienne. La Revue de Médecine Interne. 1 juin 2018;39:A156‑7.

H Bouziane, REl Ghazali, M Benzakour, M Moudatir, W Bouissar, K Echchilali, FZ Alaoui, H Elkabli, Eye and systemic lupus erythematosus: About 4 cases. 2014 ;Lu79.

Giorgi D, Pace F, Giorgi A, et al. Retinopathy in systemic lupus erythematosus: Pathogenesis and approach to therapy. Hum Immunol 1999;60:688–696

Asherson RA, Merry P, Acheson JF, et al. Antiphospholipid antibodies: A risk factor for occlusive vascular disease in systemic lupus erythematosus and the “primary” antiphospholipid syndrome. Ann Rheum Dis.1989;48:358–361.

Chirag P Shah, MD, Mph. Lupus Uveitis, Vasculitis, Choroidopathy, Lupus Uveitis, Vasculitis, and Choroidopathy ;2009.

Meckenstock R, Koch E, Bayle P, Therby A, Bruneel E, Monnier S et al. Systemic active lupus erythematosus (SLE) with severe retinal vascularity. The Journal of Internal Medicine. 2017;38:A180‑1.

Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18(2): 135‑49.

Luboń W, Luboń M, Kotyla P, Mrukwa-Kominek E. Understanding Ocular Findings and Manifestations of Systemic Lupus Erythematosus: Update Review of the Literature. Int J Mol Sci. 2022; 23(20):12264.

Jabs DA, Fine SL, Hochberg MC, et al. Severe retinal vasoocclusive disease in systemic lupus erythematosus. Arch Ophthalmol 1986;104:558–563

Janine, Sukhum. S, Stephen S. M Ocular involvement in systemic lupus erythematosus. PubMed. 2015;26(6): 540-5.

Dooley MA, Ginzler EM. Newer therapeutic approaches for systemic lupus erythematosus: Immunosuppressive agents. Rheum Dis Clin North Am. 2006;32:91-102

Noma H, Shimizu H, Mimura T. Unilateral macular edema with central retinal vein occlusion in systemic lupus erythematosus: A case report. Clin Ophthalmol. 2013;7:865–867. DOI:10.2147/OPTH.S44341

Arevalo JF, Lowder CY, Muci-Mendoza R. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2002;13(6): 404–410.

Kriechbaum K, Michels S, Prager F, et al. Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: A prospective study. Br J Ophthalmol. 2008;92(4):518–522.